Literature DB >> 3339931

Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).

A Blitzer1, M F Brin, S Fahn, R E Lovelace.   

Abstract

Spastic dysphonia is a condition producing a strain-strangle phonation. We have previously classified most of these patients as having focal laryngeal dystonia, a disorder of central motor processing. The initial success of recurrent nerve section in many of these patients has been followed by recurrence of symptoms in months to years. Bilateral involvement of the vocal cords with hyperfunction of the nonparalyzed vocal cord could explain these failures. Injection of botulinum toxin (BOTOX) has been effective treatment for many focal dystonias. We have treated more than 100 patients with dystonia including five with laryngeal dystonia. All of the patients laryngeal had dramatic improvement after 48 to 72 hours; benefit lasted 3 to 9 months for each injection period. BOTOX injection can be performed on awake, ambulatory patients. Bilateral treatment and titration of dose can achieve the desired degree of weakness.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3339931     DOI: 10.1288/00005537-198802000-00015

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  19 in total

Review 1.  ["Off-label use" of botulinum toxin preparations in treatment of spasmodic dysphonia. Position of the German Society of Phoniatrics and Pediatric Audiology].

Authors:  M Ptok; R Schönweiler; T Nawka
Journal:  HNO       Date:  2004-01       Impact factor: 1.284

Review 2.  Botulinum toxin for the treatment of movement disorders.

Authors:  Mary Ann Thenganatt; Stanley Fahn
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

3.  Intrinsic properties of the adult human mylohyoid muscle: neural organization, fiber-type distribution, and myosin heavy chain expression.

Authors:  Min Ren; Liancai Mu
Journal:  Dysphagia       Date:  2005       Impact factor: 3.438

4.  Botulinum toxin for treatment of spastic dysphonia.

Authors:  C Anonsen
Journal:  West J Med       Date:  1989-04

5.  The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.

Authors:  R Whurr; M Lorch; H Fontana; G Brookes; A Lees; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

Review 6.  [Treatment of laryngeal movement disorders with botulinum toxins: part 1: History and mode of action].

Authors:  C Schwemmle; M Ptok
Journal:  HNO       Date:  2007-05       Impact factor: 1.284

Review 7.  Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience.

Authors:  Andrew Blitzer; Mitchell F Brin; Kristina Simonyan; Laurie J Ozelius; Steven J Frucht
Journal:  Laryngoscope       Date:  2017-12-08       Impact factor: 3.325

8.  A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia.

Authors:  P Zwirner; T Murry; G E Woodson
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 9.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

Review 10.  Treatment of focal dystonias with botulinum neurotoxin.

Authors:  Mark Hallett; Reiner Benecke; Andrew Blitzer; Cynthia L Comella
Journal:  Toxicon       Date:  2008-12-13       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.